Clinical Trial Update: The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of sodium zirconium cyclosilicate on albuminuria in patients with type 2 diabetes and hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus with Kidney Complications

Drugs mentioned

• Sodium Zirconium Cyclosilicate (sodium zirconium cyclosilate)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Type 2 Diabetes Mellitus With Kidney Complications | Phase 4 | Status: UNKNOWN